Goldman Sachs’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9M | Buy |
1,187,101
+419,835
| +55% | +$10.9M | ﹤0.01% | 1459 |
|
|
2025
Q1 | $18.8M | Sell |
767,266
-51,401
| -6% | -$1.26M | ﹤0.01% | 1753 |
|
|
2024
Q4 | $23.5M | Buy |
818,667
+169,093
| +26% | +$4.85M | ﹤0.01% | 1656 |
|
|
2024
Q3 | $24.5M | Buy |
649,574
+178,484
| +38% | +$6.73M | ﹤0.01% | 1585 |
|
|
2024
Q2 | $14.9M | Buy |
+471,090
| New | +$14.9M | ﹤0.01% | 1786 |
|